Table 5.

Incidence of adverse events (at least 5% incidence in any group)

Adverse event	Fingolimod 0.5 mg	Fingolimod 1.25 mg	Placebo
	n = 30	n = 29	n = 29
	n (%)	n (%)	n (%)
Patients with at least one adverse event	15 (50.0)	17 (58.6)	15 (51.7)
Preferred term
Headache	1 (3.3)	3 (10.3)	7 (24.1)
Nasopharyngitis	4 (13.3)	1 (3.4)	5 (17.2)
Oropharyngeal pain	1 (3.3)	3 (10.3)	0 (0)
Back pain	0 (0)	2 (6.9)	1 (3.4)
Diarrhoea	2 (6.7)	1 (3.4)	0 (0)